Research Article
Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy
Table 3
Survival outcomes according to the factors exhibiting independent prognostic value in multivariate analyses.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: N0/1: nodal stage 0/1; CA 19-9: cancer antigen 19-9; SIRI: systemic inflammation response index; OS: overall survival; PFS: progression-free survival. |